Levilimab (Anti-IL-6Ra / CD126)
Levilimab (Anti-IL-6Ra / CD126) is a fully human monoclonal antibody targeting interleukin-6 receptor (IL-6R). It is an inflammation-alleviating antibody and can be used for the research of rheumatoid arthritis and covid-19 treatment. MW :145.62 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2983 |
| Sku # | A2983-1mg*25 |
| Pricing | 1mg*25, $5070.00 |